The independent source for health policy research, polling, and news.
6,081 - 6,100 of 15,453 Results
Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss the new abortion bans passed in Alabama and Georgia; bipartisan congressional efforts to end “surprise” out-of-network medical bills; and a new public option health insurance plan soon to be available in Washington state.
For the first time, the federal government is measuring the quality of rehab services in nursing homes for the millions of older adults who need post-hospitalization care.
The administration’s position on a pending lawsuit to get the Affordable Care Act is one of the reasons experts said there’s cause for skepticism.
KHN’s Julie Rovner discusses on WBUR’s “Here and Now” some of the surprising ramifications that could follow abortion restrictions passed recently in some states.
Kathy Brandt and Kim Acquaviva are both leaders in the world of hospice and palliative care. When Brandt learned she was dying of ovarian cancer, the couple decided it could be a teachable moment.
Walmart, the nation’s largest private employer, is recommending that employees and dependents use one of 800 imaging centers identified as providing trustworthy care.
Kaiser Health News’ Julie Rovner talks about a package of health care bills that Democrats plan to push through the House this week during an interview on “Here and Now.”
After depending on the local hospital for more than a century, Fort Scott residents now are trying to cope with life without it.
The claim by Democratic presidential candidate Eric Swalwell is correct but could use more context and clarification.
California’s governor Friday scuttled his plan to siphon public health money from four counties to help provide health coverage for unauthorized immigrants ages 19 through 25.
A talking point used by House Speaker Nancy Pelosi refers to all three of these distinct concepts in a way that could magnify public misperceptions.
A large public hospital in Los Angeles gets over 1,000 unidentified patients a year. Most are quickly identified, but some require considerable gumshoe work — a task that can be complicated by medical privacy laws.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
President Donald Trump called for an end to the "unpleasant surprise" of certain medical bills on Thursday. NPR reporter Selena Simmons-Duffin covered the White House announcement, which featured two patients from the KHN-NPR "Bill of the Month" series.
The savvy “Right to Desire” campaign relies on feminist messages and social media to raise patient awareness about low libido. Addyi, the only drug currently approved to treat it, has shown limited effectiveness.
Despite the broad agreement on the need to address surprise bills, insurers and health care providers oppose the other side’s preferred solutions.
California officials announced a ban on chlorpyrifos, a widely used pesticide that has been linked to lower IQs, lower birth weights and other developmental issues in children, even as the federal government fights to protect it.
Joanne Kenen of Politico, Jen Haberkorn of the Los Angeles Times and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss the latest news about the Trump administration’s effort to allow health care practitioners and organizations to refuse to provide care or refer patients for services that violate their conscience or religion. Also this week, the administration orders TV ads for prescription drugs to include list prices. And Tennessee wants free rein from the federal government to run its Medicaid program. Plus, Rovner interviews Joan Biskupic, author of a new book on Chief Justice John Roberts, about the behind-the-scenes negotiations that led to the 2012 ruling upholding the constitutionality of the Affordable Care Act.
Findings released Thursday by the Rand Corp. highlight how reimbursement rates vary nationally and the impact the charges have on the nation’s high cost of health care.
As part of his plan to tamp down drug pricing, President Donald Trump wants pharmaceutical companies to provide cost information in drug ads — just like side effects.
© 2026 KFF